CMPI President Peter Pitts discusses drug rebates and drug costs (at the 16 minute mark)
Will Targeting Drug Rebates Help Cut the Cost of Prescription Drugs?
RECENT NEWS
New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases
Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients... Read more
Qualifying Single-Source Drug Policy, Medicare Price Negotiation, and the Incentives for Meaningful Post-Approval Innovation
CMS should demand evidence from manufacturers and be prepared to defend its own assumptions about innovation. Its next st... Read more
Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs
Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis... Read more